Literature DB >> 26907915

Botulinum Toxin Confers Radioprotection in Murine Salivary Glands.

Youssef H Zeidan1, Nan Xiao2, Hongbin Cao2, Christina Kong3, Quynh-Thu Le2, Davud Sirjani2.   

Abstract

PURPOSE: Xerostomia is a common radiation sequela, which has a negative impact on the quality of life of patients with head and neck cancer. Current treatment strategies offer only partial relief. Botulinum toxins (BTX) have been successfully used in treating a variety of radiation sequelae such as cystitis, proctitis, fibrosis, and facial pain. The purpose of this study was to evaluate the effect of BTX on radiation-induced salivary gland damage. METHODS AND MATERIALS: We used a previously established model for murine salivary gland irradiation (IR). The submandibular glands (SMGs) of C5BL/6 mice (n=6/group) were injected with saline or BTX 72 hours before receiving 15 Gy of focal irradiation. Saliva flow was measured 3, 7, and 28 days after treatment. The SMGs were collected for immunohistochemistry, confocal microscopy, and Western blotting. A cytokine array consisting of 40 different mouse cytokines was used to evaluate cytokine profiles after radiation treatment.
RESULTS: Irradiated mice showed a 50% reduction in saliva flow after 3 days, whereas mice preinjected with BTX had 25% reduction in saliva flow (P<.05). Cell death detected by TUNEL staining was similar in SMG sections of both groups. However, neutrophil infiltrate, detected by myeloperoxidase staining, was 3-fold lower for the BTX treated mice. A cytokine array showed a 2-fold upregulation of LPS-induced chemokine (LIX/CXCL5) 3 days after IR. BTX pretreatment reduced LIX levels by 40%. At 4 weeks after IR, the saline (control) group showed a 40% reduction in basal SMG weight, compared with 20% in the BTX group. Histologically, BTX-pretreated glands showed relative preservation of acinar structures after radiation.
CONCLUSIONS: These data suggest that BTX pretreatment ameliorates radiation-induced saliva dysfunction. Moreover, we demonstrate a novel role for CXCL5 in the acute phase of salivary gland damage after radiation. These results carry important clinical implications for the treatment of xerostomia in patients with head and neck cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26907915      PMCID: PMC4839970          DOI: 10.1016/j.ijrobp.2015.12.371

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  38 in total

1.  Botulinum toxin for salivary disorders in the treatment of head and neck cancer.

Authors:  Armin Steffen; Katrin Hasselbacher; Sabrina Heinrichs; Barbara Wollenberg
Journal:  Anticancer Res       Date:  2014-11       Impact factor: 2.480

2.  Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Dominic H Moon; Felix Y Feng; Douglas B Chepeha; Avraham Eisbruch; Matthew H Stenmark
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

3.  Concurrent transient activation of Wnt/β-catenin pathway prevents radiation damage to salivary glands.

Authors:  Bo Hai; Zhenhua Yang; Lei Shangguan; Yanqiu Zhao; Arthur Boyer; Fei Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-16       Impact factor: 7.038

4.  A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.

Authors:  Sanjay Morzaria; Edward J Damrose
Journal:  J Voice       Date:  2010-10-16       Impact factor: 2.009

Review 5.  Current ideas to reduce or salvage radiation damage to salivary glands.

Authors:  A Vissink; P van Luijk; J A Langendijk; R P Coppes
Journal:  Oral Dis       Date:  2014-02-28       Impact factor: 3.511

6.  Neurotrophic factor GDNF promotes survival of salivary stem cells.

Authors:  Nan Xiao; Yuan Lin; Hongbin Cao; Davud Sirjani; Amato J Giaccia; Albert C Koong; Christina S Kong; Maximilian Diehn; Quynh-Thu Le
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

7.  A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth.

Authors:  Nan Xiao; Hongbin Cao; Che-Hong Chen; Christina S Kong; Rehan Ali; Cato Chan; Davud Sirjani; Edward Graves; Albert Koong; Amato Giaccia; Daria Mochly-Rosen; Quynh-Thu Le
Journal:  Clin Cancer Res       Date:  2013-06-28       Impact factor: 12.531

8.  Botulinum toxin A for children with salivary control problems.

Authors:  Jenny Montgomery; Sarah McCusker; Jane Hendry; Eleanor Lumley; Haytham Kubba
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-09-06       Impact factor: 1.675

9.  Prevention of radiation-induced salivary gland dysfunction utilizing a CDK inhibitor in a mouse model.

Authors:  Katie L Martin; Grace A Hill; Rob R Klein; Deborah G Arnett; Randy Burd; Kirsten H Limesand
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

10.  Parasympathetic stimulation improves epithelial organ regeneration.

Authors:  Sarah M Knox; Isabelle M A Lombaert; Candace L Haddox; Shaun R Abrams; Ana Cotrim; Adrian J Wilson; Matthew P Hoffman
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  5 in total

1.  Advances on mechanism and treatment of salivary gland in radiation injury.

Authors:  Shen-Sui Li; Chen-Zhou Wu; Xiang-He Qiao; Chun-Jie Li; Long-Jiang Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

2.  The Future of Radiobiology.

Authors:  David G Kirsch; Max Diehn; Aparna H Kesarwala; Amit Maity; Meredith A Morgan; Julie K Schwarz; Robert Bristow; Sandra Demaria; Iris Eke; Robert J Griffin; Daphne Haas-Kogan; Geoff S Higgins; Alec C Kimmelman; Randall J Kimple; Isabelle M Lombaert; Li Ma; Brian Marples; Frank Pajonk; Catherine C Park; Dörthe Schaue; Phuoc T Tran; Eric J Bernhard
Journal:  J Natl Cancer Inst       Date:  2018-04-01       Impact factor: 13.506

3.  Inhibition of the Continuum of Radiation-Induced Normal Tissue Injury by a Redox-Active Mn Porphyrin.

Authors:  Samuel R Birer; Chen-Ting Lee; Kingshuk Roy Choudhury; Kenneth H Young; Ivan Spasojevic; Ines Batinic-Haberle; James D Crapo; Mark W Dewhirst; Kathleen A Ashcraft
Journal:  Radiat Res       Date:  2017-05-18       Impact factor: 2.841

Review 4.  Experimental Animal Model Systems for Understanding Salivary Secretory Disorders.

Authors:  Ji-Youn Kim; Chang-Hyeon An; Jae-Young Kim; Jae-Kwang Jung
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 5.  Diagnosis, Prevention, and Treatment of Radiotherapy-Induced Xerostomia: A Review.

Authors:  Yanli Li; Xuehan Li; Runxuan Pang; Guang Yang; Mingxu Tian; Tengyu Zhao; Yunhan Sun; Eui-Seok Lee; Heng Bo Jiang; Jianmin Han
Journal:  J Oncol       Date:  2022-08-27       Impact factor: 4.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.